CrossRef The Association Between Continuous Glucose Monitoring-Derived Metrics and Cardiovascular Autonomic Neuropathy in Outpatients with Type 2 Diabetes Min Young Kim, Gyuri Kim, Ji Yun Park, Min Sun Choi, Ji Eun Jun, You-Bin Lee, Sang-Man Jin, Kyu Yeon Hur, Jae Hyeon Kim Diabetes Technology & Therapeutics.2021
Remarkably, NDI1 expression led to improved glucose tolerance and reduced insulin release during the glucose tolerance test (GTT) (Fig
In addition, a retrospective database study estimated that patients persistence of injectable semaglutide treatment was significantly higher than treatment with dulaglutide, liraglutide and exenatide XR (Table 1) (Uzoigwe et al., 2021)
116, S736
We know this from experience, and it happens that patients whose operations were not optimal come to us for corrections